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In quiescent cultures of Swiss 3T3 cells, platelet-derived growth factor or fibroblast growth factor known 
to induce both protein kinase C activation and Ca2+ mobilization raised c-fos mRNA. This action of the 
growth factors was mimicked by the specific activators for protein kinase C, such as phorbol esters and 
a membrane-permeable synthetic diacylglycerol, and also by the Caz+ ionophores, such as A23 187 and iono- 
mycin. Prostaglandin E, known to elevate cyclic AMP also raised c-fos mRNA, and this action was mim- 
icked by 8-bromo-cyclic AMP, dibutyryl cyclic AMP and forskolin. These results suggest that expression 
of the c-fos gene is regulated by three different intracellular messenger systems, protein kinase C, CaZ+ and 
cyclic AMP, in Swiss 3T3 ceils. 
Oncogene Growth substance Protein kinase C Ca’+ CAMP (Fibroblas t) 
1. INTRODUCTION 
Various growth factors including PDGF, FGF 
and PGEl stimulate DNA synthesis and cell divi- 
sion in the presence of insulin in Swiss 3T3 cells 
[l-4]. In this cell line, PDGF and FGF have been 
shown to induce phosphoinositide turnover 
resulting in both diacylglycerol formation and 
Ca’+ mobilization [5-81 whereas PGEl has been 
shown to elevate cyclic AMP [4]. It is well 
established that the diverse actions of 
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Abbreviations: PDGF, platelet-derived growth factor; 
FGF, fibroblast growth factor; PGE1, prostaglandin El; 
protein kinase A, cyclic AMP-dependent protein kinase; 
[Ca”]i, cytoplasmic free Ca2+ concentration; TPA, 
12-0-tetradecanoylphorbol-13-acetate; PDBu, phorbol- 
12,13-dibutyrate; 4~PDD, 4cu-phorbol-12,13-didecano- 
ate; OAG, 1-oleoyl-2-acetylglycerol; 8-Br-CAMP, 
&bromo-cyclic AMP; BtzcAMP, dibutyryl cyclic AMP; 
DMEM, Dulbecco’s modified Eagle’s medium 
diacylglycerol, Ca2+ and cyclic AMP are mediated 
through the activation of protein kinase C, 
calmodulin and protein kinase A, respectively 
[9-l 11. We have recently obtained the evidence 
that PGEl elevates [Ca2+]i as well as cyclic AMP 
in Swiss 3T3 cells (Yamashita et al., submitted). 
Moreover, we have demonstrated that these three 
intracellular messengers, diacylglycerol, Ca2+ and 
cyclic AMP, are responsible for the c-myc gene ex- 
pression stimulated by the respective growth fac- 
tors in this cell line (Yamashita et al., submitted) 
[8,12], and that the action of diacylglycerol is 
mediated through the activation of protein kinase 
C PI. 
Stiles and his colleagues [13] have proposed that 
the competence gene family activated directly by 
PDGF plays essential roles in the regulation of cell 
division in BALB/c-3T3 cells. They have 
demonstrated that lo-30 genes may belong to this 
gene family [13,14], and that the c-myc gene is one 
of them [ 13,151. The c-fos gene has also been 
shown to belong to this gene family and to be ac- 
tivated by the action of PDGF and FGF in 
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BALB/c-3T3 cells [13,16-181. However, it has not 
been clarified whether expression of this gene is 
controlled by protein kinase C, Ca2+ or cyclic 
AMP in Swiss 3T3 cells. The present communica- 
tion describes that expression of the c-fos gene is 
regulated by these three intracellular messenger 
systems in Swiss 3T3 cells as described for the c- 
myc gene (Yamashita et al., submitted) [8,12]. 
2. MATERIALS AND METHODS 
2.1. Materials 
pBR322 plasmid containing the v-fos gene 
(pfos-1) was a generous gift from Drs T. Sugiyama 
and R. Takahashi (Kobe University School of 
Medicine, Kobe, Japan) who originally obtained it 
from Dr I.M. Verma (Molecular Biology and 
Virology Laboratory, The Salk Institute, San 
Diego, USA). Swiss 3T3 cells, bovine pituitary 
FGF and human PDGF were kindly donated by Dr 
E. Rozengurt (Imperial Cancer Research Fund, 
London, England), Dr D. Gospodarowicz (Univer- 
sity of California, San Francisco, USA) and Dr 
T.F. Deuel (Washington University, St. Louis, 
USA), respectively. PGEl was purchased from 
Funakoshi Pharmaceutical Co. TPA and PDBu 
were from CCR, 4cu-PDD from Sigma and A23 187 
and ionomycin from Calbiochem. OAG was syn- 
thesized as described [19]. 8-Br-CAMP and 
Bt2cAMP were from Yamasa Shoyu Co. Forskolin 
was a gift from Nihonkayaku Co. [a-32P]dCTP 
(3000 Ci/mmol) was from Amersham and other 
materials and chemicals were obtained from com- 
mercial sources. 
2.2. Cell culture 
Stock cultures of Swiss 3T3 cells were main- 
tained under the conditions described [20]. For ex- 
periments, the cells were plated at a density of 1.5 
x 10’ cells/lOO-mm dish with DMEM containing 
10% fetal calf serum and refed with the same 
medium after 2 days. Such cultures were used at 
least 5 days after the last change of medium. These 
cells were confluent and quiescent. The cells were 
washed twice with DMEM and employed for each 
experiment. 
2.3. Measurement of c-fos mRNA 
The washed Swiss 3T3 cells were stimulated by 
various agents in 5 ml of DMEM containing 0.1% 
40 
bovine serum albumin for 60 min at 37°C. Each 
reaction was terminated by chilling the cells on ice 
and washed twice with ice-cold phosphate- 
buffered saline. Total RNA was extracted from the 
cells by the procedure described by Chirgwin et al. 
[21] using CsCl gradient centrifugation. For dot 
blot analysis, total RNA samples were dotted onto 
nitrocellulose filters under a slow vacuum. After 
baking, the filters were hybridized for 48 h at 42°C 
with 32P-labeled DNA probe and the unbound 
fraction was removed by extensive washing. The 
filters were autoradiographed using intensifying 
screens for 24 h at -70°C and the dots were ex- 
cised and counted in a scintillation counter. The 
amount of the probe hybridized was proportional 
to the amount of RNA on the filter at a range from 
1 to 10 pg. The levels of c-fos mRNA are expressed 
as cpm/6 pg of total RNA. The 32P-labeled DNA 
probe was a nick-translated 1 .O-kb v-fos-specific 
PstI fragment from pfos-1 of cloned FBJ murine 
osteosarcoma virus proviral DNA [22]. 
3. RESULTS 
Incubation of quiescent cultures of Swiss 3T3 
cells with PDGF, FGF or PGEl caused the dose- 
dependent elevation of c-fos mRNA as shown in 
fig.1. The maximal levels obtained by PDGF and 
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Fig.1. Increases of c-fos mRNA by PDGF, FGF and 
PGE1. Quiescent cultures of Swiss 3T3 cells were 
incubated with various doses of either PDGF (A), FGF 
(B) or PGEl (C) for 60 min at 37°C. Other details are 
described in section 2. Each value is the mean of three 
independent experiments. 
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FGF were nearly the same, but the maximal level 
obtained by PGEl was about one fourth of that 
obtained by PDGF or FGF. c-fos mRNA increased 
within 15 min and reached maximal levels 
45-60 min after the stimulation by each growth 
factor, followed by gradual declines (not shown). 
The effect of protein kinase C-activating, 
Cazf-mobilizing and cyclic AMP-elevating agents 
on the levels of c-fos mRNA was examined in the 
next experiments. As shown in fig.2, TPA, a 
specific activator for protein kinase C, A23187, a 
Ca*+ ionophore, and 8-Br-CAMP, a membrane- 
permeable derivative of cyclic AMP, raised c-fos 
mRNA in a dose-dependent manner. The maximal 
levels obtained by A23187 and 8Br-CAMP were 
about two thirds and one third of that obtained by 
TPA, respectively. The time courses for increases 
of c-fos mRNA by the action of TPA, A23 187 and 
8-Br-CAMP were similar to those obtained by the 
growth factors described above; this mRNA in- 
creased within 15 min and reached maximal levels 
within 60 min after the stimulation by the respec- 
tive agents, followed by gradual declines (not 
shown). 
Table 1 shows the effect of other protein kinase 
C-activating, Ca*+-mobilizing and cyclic AMP- 
elevating agents on the levels of c-fos mRNA. 
PDBu and OAG known to be as active as TPA for 
Fig.2. Increases of c-fos mRNA by TPA, A23187 and 
8-Br-CAMP. Quiescent cultures of Swiss 3T3 cells were 
incubated with various doses of either TPA (A), A23187 
(B) or 8-Br-CAMP (C) for 60 min at 37°C. Other details 
are described in section 2. Each value is the mean of 
three independent experiments. 
Table 1 
Effect of protein kinase C-activating, Ca’+-mobilizing 
and cyclic AMP-elevating agents on the increases of c- 
fos mRNA 
Addition c-fos mRNA 
(cpm) 
None 80 
TPA (16 nM) 990 
PDBu (16 nM) 420 
4LY-PDD (16 nM) 90 
OAG (100 pg/ml) 320 
A23187 (1 AM) 720 
Ionomycin (1 PM) 1000 
S-Br-CAMP (2.5 mM) 310 
BtzcAMP (2.5 mM) 280 
Forskolin (30 PM) 210 
PGEr (30 PM) 400 
PDGF (50 ng/ml) 1670 
FGF (5 ng/ml) 1580 
Quiescent cultures of Swiss 3T3 cells were incubated 
with various agents for 60 min at 37°C. Other details are 
described in section 2. Each value is the mean of three 
independent experiments 
protein kinase C also elevated c-fos mRNA, but 
&-PDD known to be inactive for protein kinase C 
was ineffective in this capacity. Ionomycin known 
to be a specific Ca2+ ionophore was also active. 
BtzcAMP known to be another membrane- 
permeable derivative of cyclic AMP and forskolin 
known to activate adenylate cyclase increased c-fos 
mRNA to the level obtained by 8-Br-CAMP. 
4. DISCUSSION 
It has been described that PDGF and FGF in- 
duce phosphoinositide turnover resulting in both 
protein kinase C activation and Ca*+ mobilization 
in Swiss 3T3 cells [5-8,231 whereas PGEl induces 
both cyclic AMP elevation [4] and Ca2+ mobiliza- 
tion (Yamashita et al., submitted). This paper has 
demonstrated that PDGF and FGF elevate c-fos 
mRNA and that the specific activators for protein 
kinase C and the Ca2+ ionophores substitute for 
these growth factors in this action. Evidence has 
also been presented that PGEl elevates c-fos 
mRNA and that the derivatives of cyclic AMP and 
41 
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the activator for adenylate cyclase substitute for 
this growth factor in this action. These results sug- 
gest that both protein kinase C and Ca2+ are 
responsible for the PDGF- and FGF-induced in- 
crease of c-fos mRNA whereas both cyclic AMP 
and Ca2+ are responsible for the PGEi-induced in- 
crease of this mRNA in Swiss 3T3 cells. Although 
it has not been examined whether Ca2+ and cyclic 
AMP elevate c-fos mRNA through the activation 
of calmodulin and protein kinase A, respectively, 
it is conceivable from the modes of action of these 
messengers that the actions of Ca2+ and cyclic 
AMP are mediated through the activation of the 
respective effecters. 
The c-fos gene as well as the c-myc gene has been 
shown to belong to the competence gene family in 
BALB/c-3T3 cells [ 13,15,17]. We have previously 
described that the c-myc gene expression is 
regulated also by protein kinase C, Ca2+ and cyclic 
AMP in Swiss 3T3 cells (Yamashita et al., submit- 
ted) [8,12]. Although it is unknown how many 
genes belong to the competence gene family in 
Swiss 3T3 cells, our results suggest that the three 
intracellular messenger systems, protein kinase C, 
Ca2+ and cyclic AMP, are involved in the expres- 
sion of at least these two competence genes which 
are directly regulated by growth factors in this cell 
line. 
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